Hints and tips:
Showing results for Roche Diagnostics Operations, Inc.
Related Special Reports
...Roche said it was also reviewing its manufacturing operations to improve efficiency. It recently sold a large site in California to contract manufacturer Lonza for $1.2bn....
...He was previously chief of the Roche diagnostics business, and is now focusing on improving the future of the pharmaceutical division with internal development and deals, after disappointments including...
...GTCR has thrived quietly under its current co-chief executives Collin Roche and Dean Mihas who oversee everyday operations. Golder died in 2000 and Rauner stepped away after his stint in politics....
...Abcam creates products for scientific research, including antibodies and other materials that can be used as drugs or diagnostics, partnering with companies and non-profits such as Roche and Cancer Research...
...“There is no way that PCR capacity is going to double in the next three months,” said James Davis, an executive vice-president at Quest Diagnostics, in an interview with the Financial Times, referring to...
...Job moves Severin Schwan will step down next March as chief executive of Swiss pharma group Roche. He will be nominated as chair of the board....
...The latter’s early research and development centre continues to operate independently within Roche out of San Francisco, headquarters of the pharma company’s US operations....
...A push by Narasimhan to make Sandoz’s manufacturing and other operations independent of Novartis is nearly complete. But there are still some benefits from the combination....
...It runs its international operations from Switzerland and sells its drugs in more than 50 countries, including the UK....
...drugs, and diagnostics do not fail in the face of new strains....
...Roche, the Swiss pharmaceutical company, reported a 55 per cent jump in diagnostic sales in the first quarter thanks to strong demand for Covid-19 tests, including a new product to track virus variants....
...Dr Schleifer said Regeneron is working with its partner Roche, which has a large diagnostics business, to see if they could use their Covid-19 antibody tests to discover whether patients are struggling to...
...Quest Diagnostics, the largest laboratory company in the US, this week warned that there was “no way” the industry could expand molecular nasal swab testing capacity in time for the autumn, when demand is...
...Novavax is receiving up to $1.6bn from Operation Warp Speed, the US government programme designed to expedite vaccines for Covid-19....
...The Swiss company is one of the diagnostics “big four”, providing molecular tests that look for the presence of the virus using so-called “high throughput” machines, which can process many tests in short...
...Not enough disease was around to reach a firm conclusion, and the investigators relied on a diagnostic tool not widely available in doctors’ offices....
...Mr Soriot saw off the US group with a promise to revitalise his company’s research and development operation — but for years lucrative new drugs remained elusive and AstraZeneca’s share price languished...
...Similar co-operation is taking place for a number of new drugs and diagnostics, with support from international donors....
...The Roche tests will enable commercial labs with widely-available “cobas” diagnostic machines to produce up to 4,128 results in 24 hours....
...Qiagen has increased production and moved to 24-hour, seven-day-a-week operations at two manufacturing sites in response to the pandemic, its chief Thierry Bernard said in March....
...As Severin Schwan, chief executive of Roche, says: “We need to make distribution driven by objective criteria. Governments can really play a role.”...
...During the pandemic it has increased production and moved to 24-hour, seven-day-a-week operations at two manufacturing sites....
...The UK government has struck deals with diagnostics companies Roche and Abbott Laboratories to supply the NHS with antibody tests that will initially be reserved for healthcare workers....
...Unrelated to the virus, 2021 is likely to herald advances in genome editing — an important tool in developing Covid-19 diagnostic kits and antivirus drugs, as well as new treatments for cancer and rare diseases...
...Roche, which is one of the diagnostics “Big Four”, has also benefited from the rollout of its tests for coronavirus, which check for current and recent signs of infection through a process known as PCR and...
International Edition